The quinolinone derivative vesnarinone potentiates the cytotoxicity of doxorubicin in HL-60 leukemia cells

Manabu Yamamoto, Yoshihiko Maehara, Yoshihisa Sakaguchi, Tetsuya Kusumoto, Hideo Baba, Keizo Sugimachi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Vesnarinone, (3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone), a quinolinone derivative, is a positive inotropic agent. We examined the cytotoxicity either by vesnarinone alone or in combination with doxorubicin (DXR), in vitro. The cytotoxic effect of vesnarinone against HL-60 cells did not increase, even at concentrations as high as (50 μg/ml). The cytotoxicity of DXR, however, was enhanced after being combined with 30 μg/ml of vesnarinone. The intracellular level of DXR increased when DXR was administered after incubation with vesnarinone and the efflux of DXR was delayed when the cells were incubated in the presence of vesnarinone after DXR exposure. Flow cytometry showed that the combination of DXR and vesnarinone increased the cell population below the G0/G1 region. Vesnarinone induced DNA ladder formation, but only when these cells were incubated for 72 h, while in addition, when DXR was combined with vesnarinone, the DNA ladder formation was enhanced. Based on the above findings, we thus conclude that the cytotoxicity of DXR was enhanced when combined with vesnarinone.

Original languageEnglish
Pages (from-to)53-57
Number of pages5
JournalInternational journal of oncology
Volume10
Issue number1
Publication statusPublished - Jan 1 1997

Fingerprint

HL-60 Cells
Quinolones
Doxorubicin
Leukemia
vesnarinone
DNA
Flow Cytometry

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Yamamoto, M., Maehara, Y., Sakaguchi, Y., Kusumoto, T., Baba, H., & Sugimachi, K. (1997). The quinolinone derivative vesnarinone potentiates the cytotoxicity of doxorubicin in HL-60 leukemia cells. International journal of oncology, 10(1), 53-57.

The quinolinone derivative vesnarinone potentiates the cytotoxicity of doxorubicin in HL-60 leukemia cells. / Yamamoto, Manabu; Maehara, Yoshihiko; Sakaguchi, Yoshihisa; Kusumoto, Tetsuya; Baba, Hideo; Sugimachi, Keizo.

In: International journal of oncology, Vol. 10, No. 1, 01.01.1997, p. 53-57.

Research output: Contribution to journalArticle

Yamamoto, M, Maehara, Y, Sakaguchi, Y, Kusumoto, T, Baba, H & Sugimachi, K 1997, 'The quinolinone derivative vesnarinone potentiates the cytotoxicity of doxorubicin in HL-60 leukemia cells', International journal of oncology, vol. 10, no. 1, pp. 53-57.
Yamamoto M, Maehara Y, Sakaguchi Y, Kusumoto T, Baba H, Sugimachi K. The quinolinone derivative vesnarinone potentiates the cytotoxicity of doxorubicin in HL-60 leukemia cells. International journal of oncology. 1997 Jan 1;10(1):53-57.
Yamamoto, Manabu ; Maehara, Yoshihiko ; Sakaguchi, Yoshihisa ; Kusumoto, Tetsuya ; Baba, Hideo ; Sugimachi, Keizo. / The quinolinone derivative vesnarinone potentiates the cytotoxicity of doxorubicin in HL-60 leukemia cells. In: International journal of oncology. 1997 ; Vol. 10, No. 1. pp. 53-57.
@article{956ddf502e5d4192a9252395d8c82d8b,
title = "The quinolinone derivative vesnarinone potentiates the cytotoxicity of doxorubicin in HL-60 leukemia cells",
abstract = "Vesnarinone, (3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone), a quinolinone derivative, is a positive inotropic agent. We examined the cytotoxicity either by vesnarinone alone or in combination with doxorubicin (DXR), in vitro. The cytotoxic effect of vesnarinone against HL-60 cells did not increase, even at concentrations as high as (50 μg/ml). The cytotoxicity of DXR, however, was enhanced after being combined with 30 μg/ml of vesnarinone. The intracellular level of DXR increased when DXR was administered after incubation with vesnarinone and the efflux of DXR was delayed when the cells were incubated in the presence of vesnarinone after DXR exposure. Flow cytometry showed that the combination of DXR and vesnarinone increased the cell population below the G0/G1 region. Vesnarinone induced DNA ladder formation, but only when these cells were incubated for 72 h, while in addition, when DXR was combined with vesnarinone, the DNA ladder formation was enhanced. Based on the above findings, we thus conclude that the cytotoxicity of DXR was enhanced when combined with vesnarinone.",
author = "Manabu Yamamoto and Yoshihiko Maehara and Yoshihisa Sakaguchi and Tetsuya Kusumoto and Hideo Baba and Keizo Sugimachi",
year = "1997",
month = "1",
day = "1",
language = "English",
volume = "10",
pages = "53--57",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - The quinolinone derivative vesnarinone potentiates the cytotoxicity of doxorubicin in HL-60 leukemia cells

AU - Yamamoto, Manabu

AU - Maehara, Yoshihiko

AU - Sakaguchi, Yoshihisa

AU - Kusumoto, Tetsuya

AU - Baba, Hideo

AU - Sugimachi, Keizo

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Vesnarinone, (3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone), a quinolinone derivative, is a positive inotropic agent. We examined the cytotoxicity either by vesnarinone alone or in combination with doxorubicin (DXR), in vitro. The cytotoxic effect of vesnarinone against HL-60 cells did not increase, even at concentrations as high as (50 μg/ml). The cytotoxicity of DXR, however, was enhanced after being combined with 30 μg/ml of vesnarinone. The intracellular level of DXR increased when DXR was administered after incubation with vesnarinone and the efflux of DXR was delayed when the cells were incubated in the presence of vesnarinone after DXR exposure. Flow cytometry showed that the combination of DXR and vesnarinone increased the cell population below the G0/G1 region. Vesnarinone induced DNA ladder formation, but only when these cells were incubated for 72 h, while in addition, when DXR was combined with vesnarinone, the DNA ladder formation was enhanced. Based on the above findings, we thus conclude that the cytotoxicity of DXR was enhanced when combined with vesnarinone.

AB - Vesnarinone, (3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone), a quinolinone derivative, is a positive inotropic agent. We examined the cytotoxicity either by vesnarinone alone or in combination with doxorubicin (DXR), in vitro. The cytotoxic effect of vesnarinone against HL-60 cells did not increase, even at concentrations as high as (50 μg/ml). The cytotoxicity of DXR, however, was enhanced after being combined with 30 μg/ml of vesnarinone. The intracellular level of DXR increased when DXR was administered after incubation with vesnarinone and the efflux of DXR was delayed when the cells were incubated in the presence of vesnarinone after DXR exposure. Flow cytometry showed that the combination of DXR and vesnarinone increased the cell population below the G0/G1 region. Vesnarinone induced DNA ladder formation, but only when these cells were incubated for 72 h, while in addition, when DXR was combined with vesnarinone, the DNA ladder formation was enhanced. Based on the above findings, we thus conclude that the cytotoxicity of DXR was enhanced when combined with vesnarinone.

UR - http://www.scopus.com/inward/record.url?scp=0031037672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031037672&partnerID=8YFLogxK

M3 - Article

C2 - 21533343

AN - SCOPUS:0031037672

VL - 10

SP - 53

EP - 57

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 1

ER -